Elrod S V, Leslie S W
J Pharmacol Exp Ther. 1980 Jan;212(1):131-6.
Male Sprague-Dawley rats (250--300 g) were randomly divided into three experimental groups: control, acute (received a single dose of 60 mg/kg of phenobarbital i.p.) and tolerant (received dietary phenobarbital, 2.5 mg/kg of milled Purina Lab Chow, for 13 days). Cerebral cortex (CT), cerebellum (CB), brain stem (BS), striatum (ST), hypothalamus (HT), and mid-brain (MB) were isolated, and the inhibitory effects of barbiturates on KCl-induced 45Ca++ influx into synaptosomes from each of these brain regions isolated from each experimental group were examined. KCl-induced 45Ca++ influx into CT, CB and BS synaptosomes from control animals was significantly depressed (39, 73 and 77% respectively) by an in vitro pentobarbital (0.3 mM) challenge. No significant depression of 45Ca++ influx was produced by pentobarbital in control synaptosomes isolated from ST, HT or MB. KCl-induced 45Ca++ influx into synaptosomes from tolerant rats was not significantly depressed by the in vitro pentobarbital challenge in any brain area. The results suggest that 45Ca++ influx into synaptosomes from CT, CB and BS is more susceptible than ST, HT and MB to inhibition by barbiturates. In addition, chronic administration of phenobarbital resulted in the adaptation of CT, CB and BS synaptosomes to the inhibitory effects of in vitro pentobarbital. This adaptation occurred in the same time frame as did the development of behavioral tolerance.
雄性Sprague-Dawley大鼠(250 - 300克)被随机分为三个实验组:对照组、急性组(腹腔注射60毫克/千克苯巴比妥单剂量)和耐受组(食用含2.5毫克/千克碾磨普瑞纳实验饲料的苯巴比妥,持续13天)。分离出大脑皮层(CT)、小脑(CB)、脑干(BS)、纹状体(ST)、下丘脑(HT)和中脑(MB),并检测巴比妥类药物对从每个实验组分离出的这些脑区的突触体中氯化钾诱导的45Ca++内流的抑制作用。体外戊巴比妥(0.3毫摩尔)刺激使对照组动物的CT、CB和BS突触体中氯化钾诱导的45Ca++内流显著降低(分别为39%、73%和77%)。戊巴比妥对从ST、HT或MB分离出的对照组突触体中的45Ca++内流没有显著抑制作用。体外戊巴比妥刺激对耐受组大鼠任何脑区的突触体中氯化钾诱导的45Ca++内流均无显著抑制作用。结果表明,CT、CB和BS突触体中的45Ca++内流比ST、HT和MB中的45Ca++内流对巴比妥类药物的抑制作用更敏感。此外,苯巴比妥的长期给药导致CT、CB和BS突触体对体外戊巴比妥的抑制作用产生适应性。这种适应性与行为耐受性的发展发生在同一时间范围内。